Chargement en cours...
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, an...
Enregistré dans:
| Publié dans: | Clin Mol Hepatol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Association for the Study of the Liver
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8273642/ https://ncbi.nlm.nih.gov/pubmed/34157830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2021.0179 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|